Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 3, no: 3 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4HTK9
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.615 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.415 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.434 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.615 |
CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.417 |
CLV_PCSK_PC1ET2_1 | 14 | 16 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.308 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.747 |
DEG_SCF_FBW7_1 | 41 | 47 | PF00400 | 0.506 |
DOC_CKS1_1 | 41 | 46 | PF01111 | 0.511 |
DOC_CYCLIN_RxL_1 | 11 | 18 | PF00134 | 0.578 |
DOC_MAPK_gen_1 | 14 | 22 | PF00069 | 0.510 |
DOC_MAPK_gen_1 | 51 | 58 | PF00069 | 0.377 |
DOC_MAPK_MEF2A_6 | 51 | 60 | PF00069 | 0.371 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.744 |
DOC_WW_Pin1_4 | 40 | 45 | PF00397 | 0.448 |
LIG_14-3-3_CanoR_1 | 129 | 139 | PF00244 | 0.736 |
LIG_14-3-3_CanoR_1 | 15 | 22 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 51 | 55 | PF00244 | 0.513 |
LIG_EH1_1 | 68 | 76 | PF00400 | 0.372 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.431 |
LIG_LIR_Apic_2 | 133 | 138 | PF02991 | 0.667 |
LIG_LIR_Nem_3 | 62 | 67 | PF02991 | 0.366 |
LIG_NRBOX | 73 | 79 | PF00104 | 0.293 |
LIG_PDZ_Class_1 | 138 | 143 | PF00595 | 0.673 |
LIG_Pex14_1 | 65 | 69 | PF04695 | 0.286 |
LIG_Pex14_2 | 61 | 65 | PF04695 | 0.383 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.667 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.372 |
LIG_SH2_GRB2like | 135 | 138 | PF00017 | 0.668 |
LIG_SH2_NCK_1 | 84 | 88 | PF00017 | 0.372 |
LIG_SH2_STAP1 | 54 | 58 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.426 |
LIG_SH3_3 | 38 | 44 | PF00018 | 0.530 |
LIG_SH3_3 | 53 | 59 | PF00018 | 0.322 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.343 |
LIG_TYR_ITSM | 60 | 67 | PF00017 | 0.360 |
MOD_CDK_SPxxK_3 | 44 | 51 | PF00069 | 0.482 |
MOD_CK1_1 | 130 | 136 | PF00069 | 0.736 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.457 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.443 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.702 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.463 |
MOD_PIKK_1 | 118 | 124 | PF00454 | 0.717 |
MOD_PIKK_1 | 59 | 65 | PF00454 | 0.398 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.620 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.408 |
MOD_Plk_1 | 103 | 109 | PF00069 | 0.653 |
MOD_ProDKin_1 | 40 | 46 | PF00069 | 0.447 |
TRG_DiLeu_BaLyEn_6 | 12 | 17 | PF01217 | 0.622 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.361 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.183 |
TRG_ER_diArg_1 | 50 | 52 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 97 | 100 | PF00400 | 0.673 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IC93 | Leptomonas seymouri | 50% | 100% |
A0A3S5H661 | Leishmania donovani | 99% | 100% |
A4H5E7 | Leishmania braziliensis | 60% | 100% |
E9AME0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4QIA9 | Leishmania major | 84% | 100% |